Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2010-11-16 00:38 2010-11-12 CRY Artivion Inc. RONALD C ELKINS Director SELL $6.00 2,000 $12,008 80,250
2010-11-12 21:11 2010-11-10 ATRC AtriCure, Inc. Hooven Michael D Director SELL $8.10 16,636 $134,718 0
2010-11-13 01:47 2010-11-10 ATRC AtriCure, Inc. Discovery Group I, LLC 10% owner BUY $8.07 19,818 $159,866 242,520
2010-11-12 21:13 2010-11-10 RMD RESMED INC Gallahue Kieran Director, Officer OPT+S $33.12 24,000 $794,873 63,590
2010-11-12 16:14 2010-11-11 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.23 20,000 $1,044,526 16,326,682
2010-11-12 21:12 2010-11-09 RMD RESMED INC FARRELL PETER C Director, Officer OPT+S $33.10 154,176 $5,102,763 451,268
2010-11-11 01:42 2010-11-09 SNWV SANUWAVE Health, Inc. Nemelka David Nephi Jr. 10% owner BUY $0.00 50,000 $0 305,000
2010-11-10 15:40 2010-11-09 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.41 60,000 $3,144,870 16,346,682
2010-11-10 21:14 2010-11-10 SYK STRYKER CORP LANCE HOWARD L Director BUY $51.85 2,000 $103,700 8,000
2010-11-10 22:36 2010-11-08 WST WEST PHARMACEUTICAL SERVICES INC JOHNSON L ROBERT Director SELL $39.18 1,000 $39,180 21,917
2010-11-11 01:28 2010-11-08 BAX BAXTER INTERNATIONAL INC GATLING JAMES M Officer OPT+S $51.36 170,300 $8,746,608 151,660
2010-11-10 01:25 2010-11-05 ATRC AtriCure, Inc. Discovery Group I, LLC 10% owner BUY $8.20 28,038 $229,914 239,666
2010-11-09 23:05 2010-11-05 RMD RESMED INC WAREHAM JOHN P Director OPT+S $33.17 48,000 $1,592,160 10,000
2010-11-10 00:51 2010-11-08 OFIX Orthofix Medical Inc. MILINAZZO ALAN Officer BUY $26.59 1,100 $29,249 28,341
2010-11-09 22:48 2010-11-08 GTF Nuo Therapeutics, Inc. JORDEN DAVID EMERSON Director BUY $0.50 7,500 $3,750 4,742,500
2010-11-09 21:33 2010-11-05 BDX BECTON DICKINSON & CO Bruder Scott P Officer SELL $77.87 474 $36,910 7,626
2010-11-09 21:22 2010-11-08 BDX BECTON DICKINSON & CO KOZY WILLIAM A Officer SELL $77.55 4,190 $324,935 85,150
2010-11-10 02:04 2010-11-09 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, Officer, 10% owner SELL $37.00 3,691 $136,568 333,919
2010-11-09 18:03 2010-11-05 WST WEST PHARMACEUTICAL SERVICES INC JOHNSON L ROBERT Director SELL $39.16 2,000 $78,311 22,917
2010-11-09 00:33 2010-11-04 HAE HAEMONETICS CORP Brancazio Phillip John Officer BUY $46.34 74 $3,429 2,985
2010-11-09 00:57 2010-11-04 HAE HAEMONETICS CORP White Jonathan Officer BUY $46.34 4 $185 4,585
2010-11-09 00:40 2010-11-04 HAE HAEMONETICS CORP Gordon Mikael Officer BUY $46.34 200 $9,267 5,744
2010-11-09 00:48 2010-11-04 HAE HAEMONETICS CORP LINDOP CHRISTOPHER J Officer BUY $46.34 297 $13,762 11,237
2010-11-09 00:28 2010-11-04 HAE HAEMONETICS CORP ALLEN PETER M Officer BUY $46.34 328 $15,198 9,799
2010-11-09 04:37 2010-11-04 HAE HAEMONETICS CORP MERRIMAN RONALD Director OPT+S $58.11 7,000 $406,762 5,201
2010-11-09 00:54 2010-11-04 HAE HAEMONETICS CORP RUXIN MICHAEL I Officer BUY $46.34 215 $9,962 215
2010-11-09 00:23 2010-11-05 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.54 40,000 $2,101,744 16,406,682
2010-11-09 00:39 2010-11-04 HAE HAEMONETICS CORP FORISH JOSEPH J Officer BUY $46.34 40 $1,853 6,253
2010-11-09 00:51 2010-11-04 HAE HAEMONETICS CORP LOPEZ ALICIA R Officer BUY $46.34 150 $6,950 11,017
2010-11-09 00:44 2010-11-04 HAE HAEMONETICS CORP HANLON SUSAN M Officer BUY $46.34 160 $7,414 6,584
2010-11-09 00:21 2010-11-05 HAE HAEMONETICS CORP GRANADILLO PEDRO P Director SELL $57.72 6,000 $346,300 5,501
2010-11-09 02:31 2010-11-05 ARAY Accuray Incorporated Raanes Chris Officer OPT+S $7.00 1,000 $7,000 58,572
2010-11-08 19:23 2010-11-04 GTF Nuo Therapeutics, Inc. JORDEN DAVID EMERSON Director BUY $0.50 40,000 $19,816 4,735,000
2010-11-09 02:02 2010-11-08 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, Officer, 10% owner SELL $37.00 1,500 $55,500 333,919
2010-11-08 16:24 2010-11-04 WST WEST PHARMACEUTICAL SERVICES INC JOHNSON L ROBERT Director SELL $39.13 1,000 $39,130 24,917
2010-11-05 23:17 2010-11-03 BSX BOSTON SCIENTIFIC CORP NICHOLAS PETER M Director SELL $6.43 25,000 $160,678 3,531,021
2010-11-06 01:23 2010-11-05 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, Officer, 10% owner SELL $37.00 5,684 $210,326 333,919
2010-11-04 23:35 2010-11-02 BSX BOSTON SCIENTIFIC CORP NICHOLAS PETER M Director SELL $6.40 25,000 $159,963 3,556,021
2010-11-04 16:22 2010-11-03 MMM 3M CO Woodworth John K Officer OPT+S $85.15 10,565 $899,573 14,336
2010-11-05 00:11 2010-11-03 SYK STRYKER CORP STRYKER RONDA E Director SELL $51.40 200,000 $10,280,780 16,446,682
2010-11-04 23:11 2010-11-02 IART INTEGRA LIFESCIENCES HOLDINGS CORP ESSIG STUART Director, Officer SELL $43.03 100,000 $4,303,010 940,312
2010-11-04 23:16 2010-11-02 IART INTEGRA LIFESCIENCES HOLDINGS CORP HENNEMAN JOHN B III Officer OPT+S $42.94 100,000 $4,293,980 89,748
2010-11-04 23:36 2010-11-04 BSX BOSTON SCIENTIFIC CORP MARIO ERNEST Director BUY $6.44 10,000 $64,393 81,004
2010-11-05 02:43 2010-11-04 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, Officer, 10% owner SELL $37.00 500 $18,500 333,919
2010-11-04 23:53 2010-11-02 BAX BAXTER INTERNATIONAL INC Shapazian Carole J Uhrich Director OPT+S $50.86 4,830 $245,654 4,835
2010-11-03 23:24 2010-11-01 BSX BOSTON SCIENTIFIC CORP NICHOLAS PETER M Director SELL $6.36 25,000 $159,083 3,581,021
2010-11-04 04:13 2010-11-01 RMD RESMED INC Darkin Donald Officer OPT+S $31.29 10,000 $312,915 40,000
2010-11-03 16:30 2010-11-02 LMAT LEMAITRE VASCULAR INC O'Connor John James Director BUY $6.41 3,880 $24,873 30,480
2010-11-04 03:09 2010-11-01 ARAY Accuray Incorporated Milliken Darren J. Officer OPT+S $6.60 1,000 $6,600 13,451
2010-11-04 03:03 2010-11-01 ARAY Accuray Incorporated Raanes Chris Officer OPT+S $6.58 6,000 $39,504 58,572
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.